683 Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-500,000
| Closed | -$4.36M | – | 266 |
|
|
2023
Q1 | $4.36M | Sell |
500,000
-700,000
| -58% | -$6.1M | 0.32% | 66 |
|
|
2022
Q4 | $7.52M | Sell |
1,200,000
-270,000
| -18% | -$1.69M | 0.64% | 40 |
|
|
2022
Q3 | $5.15M | Hold |
1,470,000
| – | – | 0.4% | 60 |
|
|
2022
Q2 | $4.34M | Buy |
1,470,000
+370,000
| +34% | +$1.09M | 0.31% | 76 |
|
|
2022
Q1 | $3.42M | Hold |
1,100,000
| – | – | 0.18% | 90 |
|
|
2021
Q4 | $3.72M | Buy |
+1,100,000
| New | +$3.72M | 0.14% | 90 |
|